From the SHARP Covid-19 initiative, the article entitled “Evaluation of Real-World Mepolizumab Use in Severe Asthma across Europe – the SHARP experience with privacy-preserving federated analysis” has been recently published in ERJ Open Research. 

Project members join together in Milan to discuss key challenges in the management of severe asthma across Europe – using real-life research as part of the solution.

The SHARP Private meeting at the ERS Congress in Milan will take place face to face and virtually on the Saturday 9th of September starting at 1:00pm (CEST) ending at 2:45pm (CEST).